Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

William W. Busse*, Eugene R. Bleecker, J. Mark FitzGerald, Gary T. Ferguson, Peter Barker, Stephanie Sproule, Richard F. Olsson, Ubaldo J. Martin, Mitchell Goldman, BORA study investigators

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

221 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial'. Together they form a unique fingerprint.

Medicine & Life Sciences